Authors
Latest:
Evidence-Based Intervention Reduces C. diff Rates in Adults With CancerSMUCLA implements high-touch wipe down intervention to address the need for environmental disinfection of cancer patient care areas.
Latest:
Intra-abdominal Infection With Eikenella corrodens in a Woman With Ovarian Cancer“A bite bug in the belly.”
Latest:
Lack of Benefit of Azithromycin Use in Acute Asthma ExacerbationsRecent research shows no clinical benefits from adding azithromycin to standard treatment for adults who presented to emergency departments with acute asthma exacerbations requiring a corticosteroid course.
Latest:
Four Fungal Horsemen: Emerging Trends in Fungal Disease EpidemiologyNew public health perspectives on aspergillosis, sporotrichosis, histoplasmosis, and coccidioidomycosis.
Latest:
FMT Proves to Be Effective and Acceptable Treatment for rCDIFecal microbiota transplantation (FMT) is a widely accepted, safe, and effective treatment for recurrent Clostridium diffi­cile infection (rCDI), but does the cure endure?
Latest:
Exploring the Threat of MDR-TB in the United StatesThe virulent pathogen has significant individual and public health implications.
Latest:
Pharmaceutical Companies and Antimicrobial Stewardship: Save Us a SeatThe pharmaceutical industry plays an essential role in advancing antimicrobial stewardship and addressing the growing threat of resistant pathogens.
Latest:
A Long-Term Care Antimicrobial Stewardship Certificate Program for Pharmacists: Filling an Unmet NeedThis training will empower pharmacists practicing in LTC facilities to develop antimicrobial stewardship programs, improve patient outcomes related to infectious diseases, and facilitate compliance with CMS requirements.
Latest:
Novel Cephalosporin Agent Shows Promise for Complicated UTIsA new agent in the antibiotic pipeline, cefiderocol, has proved to be effective against complicated urinary tract infections (UTIs).
Latest:
Hepatitis A Outbreaks on the Rise in the USAn epidemiologist explores the changing epidemiology of a familiar disease.
Latest:
Psychobiotics: What Do We Know and Where Do We Go?Review authors discuss current knowledge regarding psychobiotics and identify questions for future research.
Latest:
Staying Ahead of the Curve: Implementing AUC-Guided Vancomycin DosingEvidence suggests AUC-guided vancomycin dosing is a safer method than traditional trough-guided dosing.
Latest:
An Estimated 5700 Zika Cases Went Unreported in 2017 Cuban OutbreakAlthough Cuba reported no cases of Zika virus in 2017 and 2018, investigators used travel data and genomic epidemiology to uncover a large, “hidden” Zika outbreak.
Latest:
SEP-1 Bundle Compliance Associated with Reduced Hospital ReadmissionsAs the leading cause of unplanned 30-day hospital readmissions, sepsis affects more than 1.5 million individuals each year.
Latest:
Candida auris: Coming Soon to a Facility Near You?Epidemiologic and clinical lessons for the uninitiated.
Latest:
Transition to Oral Therapy for the Treatment of Bacteremic Urinary Tract InfectionsSeveral recent studies provide valuable insight surrounding the appropriateness of transitioning from intravenous to oral therapy when treating bacteremic urinary tract infections.
Latest:
Phylogenetically Mapping the Evolution of the Zika Virus as It Spread Across the WorldAdriano de Bernardi Schneider, MS, PhD Candidate, Contagion® Editorial Advisory Board Member, provides a brief snapshot into some of his work on mapping the evolution of the Zika virus.
Latest:
Teaching Old Dogs New Tricks: Make the Most of Twitter to Boost ID Education, Engagement, and AdvocacyInfectious diseases clinicians turn to Twitter as a tool for education and collaboration.
Latest:
Eosinophils, Fevers, and Diarrhea With a Surprise Diagnosis in a Patient With AIDSWhen the CD4 count seems too good to be true.
Latest:
Update on Candida auris: Statistics, Detection, and a Phase 2 TrialAs of October 31, 2018, the CDC has reported 457 clinical cases of confirmed C auris infection with a majority in New York (>50%), New Jersey, and Illinois.
Latest:
Long-Acting Anti-MRSA Agents: One Dose to Cure?A review of the current literature and future directions.
Latest:
Resources Available for Patients with HIV Drug ResistanceThe panel concludes its discussion by talking about resources available for providers in managing their patients with HIV who experience drug resistance.
Latest:
Texas State Scientist on Rabies Eradication, Campus Reopening, and AMRDr. Rodney E. Rohde, clinical laboratory scientist, discusses campus reopening as well as his work on rabies eradication.
Latest:
Candida Auris: The Rise of a New Fungal ThreatCandida auris—Are we prepared for another multidrug-resistant pathogen?
Latest:
Five Ways ID Clinicians Can Take On Antibiotic Resistance: Highlights From the CDC's Latest ReportA death from an antibiotic-resistant infection occurs about every 15 minutes in the United States. The CDC’s 2019 threat report dives into national infection estimates and actions we can take to combat this threat.
Latest:
Transition to Oral Therapy for the Treatment of Bacteremic Urinary Tract InfectionsSeveral recent studies provide valuable insight surrounding the appropriateness of transitioning from intravenous to oral therapy when treating bacteremic urinary tract infections.
Latest:
Globalization of Antibiotic Stewardship Programs: The World Is WaitingThe globalization of antibiotic stewardship programs is necessary in the fight against antibiotic resis­tance.
Latest:
Suffering through COVID-19: A Doctor's Personal JourneyFrontline health care workers had a nearly 12 times higher risk of testing positive for COVID-19 compared with individuals in the general community.
